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Abstract
Ferredoxins are required to supply electrons to the cytochrome P450 enzymes
involved in cross-linking reactions during the biosynthesis of the glycopeptide
antibiotics balhimycin and vancomycin. However, the biosynthetic gene clusters
for these antibiotics contain no ferredoxin- or ferredoxin reductase-like genes. In a
search for potential ferredoxin partners for these P450s, here, we report an in silico
analysis of the draft genome sequence of the balhimycin producer Amycolatopsis
balhimycina, which revealed 11 putative Fe–S-containing ferredoxin genes. We
show that two members (balFd-V and balFd-VII), produced as native-like holo-
[3Fe–4S] ferredoxins in Escherichia coli, could supply electrons to the P450 OxyB
(CYP165B) from both A. balhimycina and the vancomycin producer Amycolatopsis
orientalis, and support in vitro turnover of peptidyl carrier protein-bound peptide
substrates into monocyclic cross-linked products. These results show that ferre-
doxins encoded in the antibiotic-producing strain can act in a degenerate manner
in supporting the catalytic functions of glycopeptide biosynthetic P450 enzymes
from the same as well as heterologous gene clusters.
Introduction
Cytochrome P450 enzymes typically catalyze the hydroxyla-
tion of substrates, using molecular oxygen and reducing
equivalents supplied by NAD(P)H. The class I bacterial
cytochrome P450 hydroxylases require a flavin-dependent
ferredoxin reductase (FdR), which is reduced by NAD(P)H,
and a ferredoxin (Fd) iron–sulfur protein to mediate
electron transfer to the P450 heme (Munro et al., 2007).
Less well studied is a small group of P450s that catalyze
oxidative phenol coupling reactions on substrates contain-
ing phenolic groups (Isin & Guengerich, 2007). Molecular
oxygen is again required, but no oxygen atom is incorpo-
rated into the product of the enzymic reaction, although
there is again a requirement for electrons, which must be
shuttled from NAD(P)H to the heme during the catalytic
cycle.
Three bacterial class I cytochrome P450 enzymes called
OxyA, OxyB and OxyC catalyze three key cross-linking
reactions in the biosynthesis of glycopeptide antibiotics of
the vancomycin/balhimycin family (Fig. 1). X-ray crystal
structures of OxyB and OxyC from the vancomycin produ-
cer Amycolatopsis orientalis confirmed that each contains a
typical P450 fold, with a conserved cysteine residue acting as
a proximal axial ligand for the heme (Zerbe et al., 2002;
Pylypenko et al., 2003). The order of the cross-linking
reactions in balhimycin biosynthesis has been defined
through gene inactivation experiments in Amycolatopsis
balhimycina (Su¨ssmuth et al., 1999; Bischoff et al., 2001a, b;
2005). The first cross-link, introduced by OxyB, is an aryl-
ether bridge (C-O-D ring) between the side chains of
residues-4 and -6. The second cross-link (D-O-E ring) is
introduced by OxyA, and the final biaryl link (the AB ring)
is created by OxyC. In vitro experiments have shown that
linear hexa- or heptapeptides attached as C-terminal thio-
esters to the pantetheinyl group of a peptide carrier protein
(PCP) domain from the glycopeptide nonribosomal peptide
synthetase (NRPS) are the preferred substrates for OxyB
(Zerbe et al., 2004; Woithe et al., 2007). The first cross-link,
therefore, is introduced while the peptide chain of the
antibiotic is still attached to the NRPS assembly line. So far,
in vitro assays with the two remaining cross-linking enzymes
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OxyA and OxyC have not been reported, and so the timing
of these cross-linking steps remains undefined. One compli-
cating factor for in vitro assays is that the natural electron
transfer proteins for all three P450s have not been defined to
date. The glycopeptide antibiotic gene clusters reported for
balhimycin, chloroeremomycin, A40926, A47934 and teico-
planin do not contain Fd or FdR genes (Donadio et al.,
2005). Only the biosynthetic gene cluster for the related
natural product complestatin contains a single Fd gene
(comK) (Chiu et al., 2001).
To advance in vitro studies of the cross-linking steps in
glycopeptide antibiotic biosynthesis, we present efforts to
identify and characterize Fd genes in the balhimycin produ-
cer A. balhimycina. The sequencing and annotation of the
entire genome is currently underway. We describe in silico
analyses, which reveal 11 different Fd genes in A. balhimyci-
na. Furthermore, we demonstrate the production and
purification of two of the newly identified Fds, as well as
their ability to participate in electron transfers to OxyB from
both A. balhimycina and A. orientalis.
Materials and methods
Bioinformatic analyses
The A. balhimycina DSM5908 genome was analyzed using a
BLAST search carried out with six Fd sequences (NP-631171,
NP-629284, NP-631715, NP-625075, NP-628054 and NP-
625924) from Streptomyces coelicolor A3(2) (Lamb et al.,
2002; Chun et al., 2007), putidaredoxin (P00259) from
Pseudomonas putida (Peterson et al., 1990; Pochapsky et al.,
1994; Sevrioukova et al., 2003) and the putative ferredoxin
comFd (AAK81833) from the complestatin producer Strep-
tomyces lavendulae (Chiu et al., 2001). Eleven putative Fds,
named balFd-I to balFd-XI, containing expect (E)-values
o 106, were identified in the whole genome of A. balhimy-
cina (Table 1). Assignment of the iron–sulfur cluster type
was achieved through a BLAST search of the nonredundant
database and a comparison with known Fds. The sequences
of the ferredoxins balFd-I to balFd-XI have been deposited
in the EMBL database under the accession numbers
FN594523–FN594533.
Cloning, expression and purification of
recombinant A. balhimycina ferredoxins
The genomic DNA of A. balhimycina DSM5908 was used as
a PCR template to amplify the genes coding for the putative
[3Fe–4S] ferredoxins balFd-V and balFd-VII. The primers
used are shown below (restriction sites underlined):
50-balFd-V: 50-TAGACCATATGAAGGTTGTTGTCGACG-30
30-balFd-V: 50-ATCTACTCGAGGGCCTCTTCGAGGGC-30
50-balFd-VII: 50-TAGACCATATGAAGGTCACCGTGGACG-30
30-balFd-VII: 50-ATCTACTCGAGCGCGTCCTCGCTCACCG-30
Fig. 1. Structures of vancomycin and balhimycin, the substrates (1 and 2) used for assays of OxyB, and the monocyclic hexapeptide product (3).
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After digestion with NdeI and XhoI, the fragments were
cloned between the NdeI/XhoI sites of plasmid pET22b
(Novagen) for expression as C-terminal His6-tagged fusion
proteins. The nucleotide sequence of each insert was con-
firmed by sequencing.
For production in Escherichia coli Rosetta2(DE3)pLysS
(balFd-V) or Origami2(DE3) (balFd-VII), terrific broth
medium (400 mL) supplemented with antibiotics and
FeSO4 (0.5 mM) was induced with isopropyl-b-D-thiogalac-
topyranoside (0.2 mM), and shaking at 30 1C for 6 h. Cell
pellets in buffer-A (25 mL, 50 mM sodium phosphate pH
7.4, 300 mM KCl, 1 mM dithiothreitol, 1 mM phenylmethyl-
sulfonyl fluoride, 1 mM benzamidine, 0.05% 2-mercap-
toethanol and 5% glycerol) were disrupted by sonication
and the cell debris was removed by centrifugation. The
supernatant was loaded onto a nickel (Ni)-nitrilotriacetic
acid (NTA) column (10 mL) in buffer-B (50 mM sodium
phosphate, pH 7.4, 300 mM KCl and 20 mM imidazole).
After washing, C-terminal His6-tagged proteins were eluted
with buffer-C (50 mM sodium phosphate, pH 7.4, 300 mM
KCl and 300 mM imidazole). The brown ferredoxins were
dialyzed against Tris/HCl buffer (50 mM, pH 7.5, 1 mM
EDTA and 20% glycerol) and concentrated by ultrafiltration
(3 kDa cut- off, Millipore). Size exclusion chromatography
(Superdex 75 10/300 GL, GE Healthcare) was carried out,
eluting with Tris/HCl buffer (50 mM, pH 7.5, 1 mM EDTA
and 20% glycerol). The purified proteins showed a single
band by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and yielded a MALDI-MS corre-
sponding to the His6-tagged proteins with loss of the
[3Fe–4S] cluster (balFd-V: m/z= 7826 [M1H]1, calc.
7826.6; balFd-VII: m/z= 7897 [M1H]1, calc. 7896.6).
The amounts of iron- and acid-labile sulfide per balFd-V
and balFd-VII were determined following published
procedures (Beinert, 1983; Fish, 1988). The iron content
was also determined by atomic adsorption spectroscopy
(AAS).
Spinach Fd (spinFd), E. coli FdR (ecoFdR) and flavodoxin
(ecoFld) were produced, following the methods described
earlier (Woithe et al., 2007).
Production of P450s
The production and characterization of P450s followed the
methods described earlier (Zerbe et al., 2002; Woithe et al.,
2007). Each purified protein showed a single band of
c. 45 kDa by SDS-PAGE, and yielded an electrospray MS
spectrum consistent with the expected protein sequence
minus the N-terminal methionine residue (data not shown).
Furthermore, the UV-Vis spectrum of each P450 showed a
Table 1. Putative ferredoxins identified in the genome of Amycolatopsis balhimycina, showing the assigned name and accession number in the EMBL
database, predicted number of amino acids and type of Fe–S cluster, as well as known ferredoxins showing high sequence similarities to each
Name
Accession no.
Amino acids
(Fd cluster type)
Significant matches in databasesw
Species Name Protein identifier % Identity
balFd-I 106 (7Fe) Mycobacterium smegmatis FdxA gi|151568127 84
FN594530 Streptomyces griseus 7Fe P13279 77
balFd-II 137 (7Fe) Mycobacterium smegmatis MC2 155 FdxA ABK72965 70
FN594531 Streptomyces coelicolor Fdx2 NP_629284 56
balFd-III 64 (3Fe) Saccharopolyspora erythraea FdxB CAM02117 48
FN594532 Streptomyces avermitilis FdxB BAC69321 45
balFd-IV 62 (3Fe) Streptomyces noursei NysM AAF71770 59
FN594533 Streptomyces nodosus AmphM AAK73508 55
balFd-V 65 (3Fe) Streptomyces hygroscopicus HbmFdx AAY28236 68
FN594523 Streptomyces griseolus Fd-2 P18325 61
balFd-VI 76 (3Fe) Nocardia farcinica Fer BAD55984 38
FN594529 Streptomyces nodosus AmphM AAK73508 37
balFd-VII 66 (3Fe) Streptomyces griseolus Fd-2 P18325 62
FN594528 Streptomyces noursei NysM AAF71770 55
balFd-VIII 64 (3Fe) Streptomyces griseolus Fd-2 P18325 53
FN594524 Streptomyces hygroscopicus HbmFdx AAY28236 50
balFd-IX 63 (3Fe) Mycobacterium tuberculosis FdxD CAA17740 52
FN594525 Nocardia farcinica Fer BAD55378 52
balFd-XI 71 (3Fe) Streptomyces peucetius Fdx876 ACE73825 44
FN594527 Streptomyces avermitilis FdxF NP_827030 40
balFd-X 103 (2Fe) Rhodococcus sp. RHA1 Fer2 YP_708187 70
FN594526 Nocardia farcinica Fer2 YP_119598 62
The 7Fe ferredoxins should contain a [4Fe–4S] and a [3Fe–4S] cluster.
wIdentified by searching the nonredundant protein sequences (nr) database using each balFd sequence.
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Soret peak at 420 1 nm and a/b bands around 569/
537 nm.
Carbon monoxide (CO)-binding assays
Assays contained P450 (10mM), NADPH (0.5 mM), glu-
cose-6-phosphate (0.5 mM), glucose-6-phosphate dehydro-
genase (0.5 U) in Tris-HCl buffer (50 mM, pH 7.5), with
ecoFdR (20 mM) and one of: (A) spinFd (10 mM); (B) ecoFld
(10mM); (C) balFd-V (10 mM); (D) balFd-VII (10mM). The
solution was divided between two cuvettes and CO was
bubbled through the sample cuvette for 20 s. Difference
spectra were recorded from 600 to 350 nm over 120 min.
Activity assays
Production and purification of apo-PCP, and the synthesis
of peptide–PCP conjugates (1 and 2, Fig. 1), were as
described previously (Woithe et al., 2007). The assay, con-
taining P450 (5–10 mM), a reduction system [Fd or ecoFld
(10mM), ecoFdR (20mM)], NADPH (1 mM), glucose-6-
phosphate (1 mM), glucose-6-phosphate dehydrogenase
(0.5 U) and a PCP-bound substrate (50–100mM) in Tris/
HCl buffer (1 mL, 50 mM, pH 7.5), was incubated at 30 1C
for 60 min. Protein was precipitated with 1/10 volume of
trichloroacetic acid (TCA) (6 M), and the resulting pellet
was resuspended in 400 mL Tris/HCl buffer (50 mM, pH 7.5)
containing 2.5% v/v hydrazine. After incubation at 30 1C for
30 min, the proteins were precipitated with TCA and
separated from the supernatant containing the peptide
hydrazides, which were analyzed by analytical reverse-phase
HPLC [Agilent Zorbax Eclipse XDB (RP C18,
250 4.6 mm, 5 mM particle, 80 A˚)] using a gradient of
5–40% MeCN/0.1% TFA in water/0.1% TFA over eight
column volumes at a flow rate of 1 mL min1.
Results and discussion
In silico analysis of the A. balhimycina genome
for ferredoxins
Fds are typically small acidic proteins containing one or two
[Fe–S] clusters. The three most common clusters found in
one-electron transfer reactions are [2Fe–2S], [3Fe–4S] and
[4Fe–4S]. A family of 7Fe Fds found in bacteria contains
both [3Fe–4S] and [4Fe-–4S] clusters within the same
polypeptide chain (Meyer, 2008). The draft genome of A.
balhimycina DSM5908 was analyzed in silico for putative
Fds. Table 1 summarizes the 11 newly identified putative Fds
from A. balhimycina, which were named balFd-I to balFd-XI
(Palmer & Reedijk, 1991).
Sequence analyses of balFd-I and balFd-II indicate high
sequence homologies (56–84% identity) toward the family
of 7Fe Fds (Fig. 2a), including FdxA from Mycobacterium
smegmatis, whose crystal structure reveals one [3Fe–4S] and
one [4Fe–4S] cluster (Ricagno et al., 2007). The seven Cys
residues that bind the [3Fe–4S][4Fe–4S] clusters in FdxA
from M. smegmatis are strictly conserved in balFd-I and
balFd-II. In vitro activity for the 7Fe Fd from Streptomyces
griseus has been demonstrated with P450soy (Trower et al.,
1990).
Eight putative Fds (balFd-III to balFd-IX; balFd-XI) show
moderate to high sequence identities toward a variety of
[3Fe–4S] Fds. In these cases, three strictly conserved Cys
residues are involved in binding the [3Fe–4S] cluster (shown
for balFd-V and balFd-VII in Fig. 2b), which strengthens the
assignment of these balFds as [3Fe–4S] Fds. Interestingly,
balFd-IV, balFd-V, balFd-VII and balFd-VIII show high
sequence homologies toward Fds that can either be found
adjacent to a P450 monooxygenase in a biosynthetic gene
cluster [NysM (Brautaset et al., 2000), AmphM (Caffrey
et al., 2001) and HbmFdx (Rascher et al., 2005)], or that has
been shown to copurify with a P450 enzyme [Fd-2 from
Streptomyces griseolus (O’Keefe et al., 1991)]. These results
suggest that the newly identified Fds might play a role in
supporting the activity of P450 enzymes in A. balhimycina.
The balFd-X exhibits high sequence similarities toward
[2Fe–2S] proteins (Table 1 and Fig. 2c), in particular, Pdx
from P. putida, the natural redox partner of P450cam, with
which it shares a sequence identity of 42% and contains the
same four highly conserved cysteine residues involved in
binding the Fe–S cluster (Matsubara & Saeki, 1992). The
genomes of S. coelicolor A3(2) (Bentley et al., 2002),
Streptomyces avermitilis (Ikeda et al., 2003), S. griseus
(Ohnishi et al., 2008), Mycobacterium tuberculosis (Cole
et al., 1998) and Saccharopolyspora erythraea (Oliynyk et al.,
2007) do not contain proteins with similarities to Pdx or
balFd-X.
Shotgun sequencing of the genome of A. balhimycina is
finished, but manual annotation is still ongoing. Most
importantly, no gene encoding a putative Fd can be found
approximately 360 kbp upstream or downstream of the
balhimycin biosynthetic gene cluster. However, balFd-V
and balFd-VII are each located in close vicinity to other
putative P450s, as well as FdRs, of unknown function.
Production and characterization of
recombinant ferredoxins
The putative 7Fe Fd balFd-I, three of the putative [3Fe–4S]
Fds balFd-IV, balFd-V and balFd-VII, as well as the pre-
sumed [2Fe–2S]-containing balFd-X were selected here for
more detailed biochemical studies. Attempts were made to
produce each of the five putative Fds in E. coli as a
C-terminal His6-tagged recombinant protein. However,
only balFd-V and balFd-VII could be produced efficiently
as cofactor-containing proteins. The production of balFd-I
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and balFd-IV in E. coli Rosetta2(DE3)pLysS yielded colorless
His6-tagged recombinant proteins, lacking the chromo-
phore expected from intact Fe–S clusters. Overexpression
of the balFd-X gene in E. coli yielded no recombinant
protein with the expected mass. Further studies on these
Fds were not pursued here.
The production of balFd-V and balFd-VII yielded red-
brown-colored holo-proteins that were purified by Ni-NTA
and gel filtration chromatography. Each protein eluted from
a gel filtration column (Superdex 75 10/300 GL, GE Health-
care) with an apparent mass of about 24–26 kDa (O’Keefe
et al., 1991). Both proteins were Z90% homogeneous
by SDS-PAGE and analytical reverse-phase HPLC, and
yielded ions consistent with the expected masses for the
apo-forms by MALDI-MS (for balFd-V m/z= 7826
[M1H]1, calc. 7826.6; for balFd-VII m/z= 7897 [M1H]1,
calc. 7896.6).
The recombinant balFd-V and balFd-VII showed broad
UV-Vis absorption maxima at 280–300 nm and 412 nm
(Fig. 3), which are typical for oxidized [3Fe–4S] or
[4Fe–4S] Fds (Jouanneau et al., 1990; O’Keefe et al., 1991).
By comparison, the recombinant His6-tagged [2Fe–2S]
spinFd showed the expected absorbance maxima at 275,
328, 420 and 463 nm (Armengaud et al., 2000).
Fig. 2. (a) Sequence comparison of balFd-I and
balFd-II, with other known [3Fe–4S][4Fe–4S] (7Fe)
Fds. Cys residues that bind the [3Fe–4S] cluster
are shown with () and those that bind the
[4Fe–4S] cluster are shown with (.). (b) Sequence
comparisons of balFd-V, balFd-VII with other
known [3Fe–4S] Fds. Cys residues that bind the
[3Fe–4S] cluster are shown with (). (c) Sequence
comparisons of balFd-X with other known
[2Fe–2S] Fds. Cys residues that bind the [2Fe–2S]
cluster are shown with (). Identical residues are
shaded gray.
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Extinction coefficients for balFd-V and balFd-VII were
determined using AAS to establish the iron content, with the
assumption that one [3Fe–4S] cluster is present in each
polypeptide chain (e412 = 18 300 M
1 cm1 for balFd-V and
14 660 M1 cm1 for balFd-VII). The values found are close
to those reported for two Fds from S. griseolus: Fd-1
(e410 = 17 000 M
1 cm1) and Fd-2 (e410 = 20 100 M
1 cm1)
(O’Keefe et al., 1991). The quantification of acid-labile
sulfide was also carried out using a colorimetric assay
(Beinert, 1983). Under optimized conditions, the assays
yielded 4.01 0.5 and 3.84 0.5 mol S mol1 protein for
balFd-V and balFd-VII, respectively.
Ferredoxin-mediated reduction
of P450 heme iron
The OxyB P450 enzymes from the vancomycin biosynthetic
gene cluster of A. orientalis (vanOxyB) and from the
balhimycin biosynthetic gene cluster of A. balhimycina
(balOxyB) were used for CO-binding and activity assays.
Upon reduction of the P450 heme iron from Fe(III) to Fe(II)
using sodium dithionite and exposure to CO, both enzymes
showed a characteristic Soret absorbance maximum at
450 nm. Following formation of the Fe(II)–CO complex, a
new species is formed over 1–2 h, absorbing at about
420 nm, the so-called P420 form, which arises by protona-
tion of the proximal cysteine thiolate ligand of the heme
iron (Perera et al., 2003; Dunford et al., 2007).
CO-binding assays were also performed with each P450
and the primary electron transfer proteins ecoFdR and one
of spinFd, balFd-V, balFd-VII or ecoFld. These assays
monitor the ability of each donor to transfer one electron
to the P450 heme Fe(III), followed by binding of CO to the
Fe(II) form. Although the proteins tested have diverse
species origins (spinach, E. coli and A. balhimycina) and
cofactor types ([2Fe–2S], FMN, [3Fe–4S]), all four were
able to reduce the Fe(III) heme of vanOxyB, albeit to
different extents. The plant spinFd rapidly (o 6 min) led
to up to 75% conversion (relative to dithionite) to the
vanOxyB P450-form, whereas with ecoFld, a maximum of
40% conversion was attained only after 40 min. A rapid
formation of the P450 from vanOxyB (o 10 min) was also
observed using either Fd from A. balhimycina, with 60%
conversion with balFd-V and 45% with balFd-VII.
The OxyB enzymes from the balhimycin and vancomycin
pathways share 88% sequence identity. Nevertheless, some
differences were observed between these enzymes in their
abilities to accept electrons from the four primary redox
partners. Thus, both balOxyB and vanOxyB are rapidly
(o 5–6 min) and efficiently (80%) converted into the P450
form by spinFd, but the emergence of the P450 form with
balFd-V and balFd-VII was slower and reached at best 40%
(balFd-V) and 20% (balFd-VII) of the response seen with
sodium dithionite. With balOxyB, essentially no reduction
was observed using ecoFld.
These CO-binding assays do not indicate whether or not a
second electron transfer can occur to the heme as required in
the full P450 catalytic cycle. For example, spinFd can donate
the first electron to camphor-bound P450cam, but allows no
hydroxylation of substrate (Lipscomb et al., 1976). To
address this point, assays were also carried out with peptide
substrates of OxyB.
Ferredoxin-mediated catalytic activity
The assay for the catalytic activity of OxyB is that described
in an earlier work (Zerbe et al., 2004; Woithe et al., 2007,
2008; Geib et al., 2008). The substrates used are the model
hexa- and heptapeptides 1 and 2 (Fig. 1), which are closely
related to the expected intermediates occurring during
glycopeptide biosynthesis. Each peptide is covalently linked
as a C-terminal thioester to an isolated recombinant PCP
domain from the seventh module of the vancomycin NRPS.
For ease of synthesis (Li & Robinson, 2005), these model
peptides contain tyrosine at positions-2 and -6, rather than
b-hydroxy-meta-chlorotyrosine (see Fig. 1). Standard con-
ditions were used for all assays, so that a comparison of
turnover efficiencies could be obtained from the extent of
linear peptide conversion into the corresponding monocyc-
lic product. The relative amounts of remaining substrate
and monocyclic (C-O-D ring) product formed were deter-
mined after removal of the peptide from the PCP with
Fig. 3. UV-Vis absorption spectra of balFd-V
(a) and balFd-VII (b) in Tris/HCl buffer (50 mM, pH
7.5) (solid lines), and after reduction with sodium
dithionite (broken lines).
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hydrazine, and HPLC and ESI-MS analysis of the corre-
sponding peptide hydrazides (e.g. the hexapeptide hydrazide
3, Fig. 1).
The results obtained in assays with vanOxyB and balOxyB
are summarized in Table 2. Intriguingly, all of the electron
transfer proteins are able to effectively donate two electrons
to vanOxyB during the catalytic cycle, using the hexapepti-
de–PCP (1) as a substrate, with conversions to monocyclic
product (3), under the standard conditions, ranging from 60
to over 90%. The heptapeptide–PCP (2, Fig. 1), however, is
less efficiently converted into the corresponding monocyclic
product, with conversions from 10% to 60% observed. It is
important, however, to note that this heptapeptide substrate
(2) is a mixture of inseparable diastereomers (which arise
during the synthesis of the substrate) differing in configura-
tion at C(a) in residue-7. The results also suggest a more
favorable interaction between vanOxyB and spinFd or
balFd-VII, than between vanOxyB and ecoFld or balFd-V.
Similar findings were obtained in activity assays using
balOxyB. In this case, however, the differences in substrate
turnover achieved with the four electron transfer proteins,
and between the hexa- and heptapeptide substrates, are
more pronounced. Assays with balOxyB and ecoFld or
balFd-V showed only a marginal turnover of hexapeptide
(1) to a monocyclic product (3). However, with spinFd and
especially with balFd-VII, significant cyclization of the
substrate was observed (Table 2), with conversion of hex-
apeptide to monocycle similar to that seen in assays with
vanOxyB. However, the turnover of heptapeptide (2) was
significantly lower, with the best result being 15% conver-
sion to a monocyclic product achieved with balFd-VII.
These results suggest a higher discrimination between the
hexa- and heptapeptides, with the hexapeptide being more
strongly favored as a substrate by balOxyB. Finally, these
findings also indicate degeneracy in the ability of various
different Fds to support the catalytic activities of P450
coupling enzymes from different glycopeptide-producing
organisms. This property may well make it difficult to assign
a specific function to each of the individual Fds identified in
the A. balhimycina genome, at least using in vitro assays. On
the other hand, this flexibility should be an advantage in
facilitating more detailed in vitro studies of these interesting
cytochrome P450 cross-linking enzymes.
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